Quick Answer
ENvue Medical, Inc. reported R&D Expense of $909.0 thousand for fiscal year 2024.
ENvue Medical, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $909.0K | +391.4% |
| 2023 | $185.0K | -34.6% |
| 2022 | $283.0K | -3.4% |
| 2021 | $293.0K | +71.3% |
| 2020 | $171.0K | -66.7% |
| 2019 | $514.0K | -16.3% |
| 2018 | $614.0K | -11.4% |
| 2017 | $693.0K | +18.7% |
| 2016 | $584.0K | +46.4% |
| 2015 | $399.0K | -7.4% |
| 2014 | $431.0K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $221.0K | -11.2% | -77.3% |
| June 30, 2025 | $972.0K | +419.8% | +83.4% |
| March 31, 2025 | $530.0K | +338.0% | +112.9% |
| September 30, 2024 | $249.0K | +654.5% | +33.2% |
| June 30, 2024 | $187.0K | +434.3% | +54.5% |
| March 31, 2024 | $121.0K | +120.0% | +266.7% |
| September 30, 2023 | $33.0K | -32.7% | -5.7% |
| June 30, 2023 | $35.0K | -42.6% | -36.4% |
- ENvue Medical, Inc. showed an increase of +391.4% in R&D Expense compared to the prior fiscal year.
- Over the 2014–2024 period, ENvue Medical, Inc.’s r&d expense has grown by 110.9% (from $431.0 thousand to $909.0 thousand).
- The most recent figure is from ENvue Medical, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: